Free Newsletter
US population study looks at roots of disease trends
In just a matter of weeks, federal scientists will begin recruiting 100,000 pregnant women for an ambitious study designed to track children's health from the womb to the age of 21. And over that time, they expect to gain new insights into the role genetics, geography and the environment play in a wide range of diseases. The cost of the study is set at $2.7 billion.
At the top of the agenda is a better explanation for rising rates of childhood obesity, cancer, autism and behavioral problems. Other such population studies are underway in countries such as Britain, Denmark and Norway.
"Something like this has never been done in this country," said Dr. Philip J. Landrigan of the Mount Sinai School of Medicine. "It's past time for us to do this."
- read the article in the New York Times
Related Articles:
Scripps to study how people react to genetic data
New genetic map used to advance drug research
Cancer drugs should be tailored to fit patient
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage


